Liprin‐α1 contributes to oncogenic MAPK signaling by counteracting ERK activity
Open Access
- 24 January 2024
- journal article
- research article
- Published by Wiley in Molecular Oncology
- Vol. 18 (3) , 662-676
Abstract
PTPRF interacting protein alpha 1 (PPFIA1) encodes for liprin-alpha 1, a member of the leukocyte common antigen-related protein tyrosine phosphatase (LAR-RPTPs)-interacting protein family. Liprin-alpha 1 localizes to adhesive and invasive structures in the periphery of cancer cells, where it modulates migration and invasion in head and neck squamous cell carcinoma (HNSCC) and breast cancer. To study the possible role of liprin-alpha 1 in anticancer drug responses, we screened a library of oncology compounds in cell lines with high endogenous PPFIA1 expression. The compounds with the highest differential responses between high PPFIA1-expressing and silenced cells across cell lines were inhibitors targeting mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinases (ERK) signaling. KRAS proto-oncogene, GTPase (KRAS)-mutated MDA-MB-231 cells were more resistant to trametinib upon PPFIA1 knockdown compared with control cells. In contrast, liprin-alpha 1-depleted HNSCC cells with low RAS activity showed a context-dependent response to MEK/ERK inhibitors. Importantly, we showed that liprin-alpha 1 depletion leads to increased p-ERK1/2 levels in all our studied cell lines independent of KRAS mutational status, suggesting a role of liprin-alpha 1 in the regulation of MAPK oncogenic signaling. Furthermore, liprin-alpha 1 depletion led to more pronounced redistribution of RAS proteins to the cell membrane. Our data suggest that liprin-alpha 1 is an important contributor to oncogenic RAS/MAPK signaling, and the status of liprin-alpha 1 may assist in predicting drug responses in cancer cells in a context-dependent manner.Keywords
Funding Information
- Ida Montinin Säätiö
- Jane ja Aatos Erkon Säätiö
- Syöpäsäätiö
This publication has 48 references indexed in Scilit:
- Systematic identification of genomic markers of drug sensitivity in cancer cellsNature, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- Subtype and pathway specific responses to anticancer compounds in breast cancerProceedings of the National Academy of Sciences, 2011
- ERK-MAPK Drives Lamellipodia Protrusion by Activating the WAVE2 Regulatory ComplexMolecular Cell, 2011
- Liprin-α1 regulates breast cancer cell invasion by affecting cell motility, invadopodia and extracellular matrix degradationOncogene, 2010
- Inhibitor of Growth 4 Suppresses Cell Spreading and Cell Migration by Interacting with a Novel Binding Partner, Liprin α1Cancer Research, 2007
- KAI1/CD82, a tumor metastasis suppressorCancer Letters, 2006
- Identification of target genes in laryngeal squamous cell carcinoma by high-resolution copy number and gene expression microarray analysesOncogene, 2006
- GIT1 Is a Scaffold for ERK1/2 Activation in Focal AdhesionsJournal of Biological Chemistry, 2005
- Ras plasma membrane signalling platformsBiochemical Journal, 2005